HOLX
Hologic, Inc.
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
Hologic, Inc. is a healthcare company that focuses on women's health. They create and sell medical tools and tests that help doctors detect and treat health issues early, like infections and cancers. Some of their main products include tests for diseases like HIV and COVID-19, as well as imaging systems for breast exams. They also offer surgical products to help with issues like heavy bleeding or removing growths in the uterus. Overall, Hologic is dedicated to improving women's health through innovative medical solutions.
Streams of revenue
Geographic Distribution
Core Products
Business Type
Business to Business
Competitive Advantages
Key Business Risks
Meeting Expectations
Higher values indicate better execution and credibility
Recent Results
2025-02-05
2024-11-04
2024-07-29
2024-05-02
2024-02-01
2023-11-09
2023-07-31
2023-05-01
2023-02-01
2022-10-31
Takeaways
Hologic, Inc. has a strong business model focused on women's health and innovative diagnostic solutions, supported by solid financial health and market demand. Its competitive advantages in technology and a diverse product portfolio position it well for growth despite facing industry risks and economic fluctuations.
Historical data shows an impressive CAGR compared with the USA stock market average, reflecting a strong market position.
10Y annualized return is
positive but below market average
at 5.5% per year
HOLX has met or exceeded earnings expectations in
most
recent quarters (9/10)
Continue with...